Publication | Closed Access
Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease
151
Citations
38
References
2015
Year
In NAFLD and especially in NASH, short-term administration of rifaximin appears to be safe and effective.
| Year | Citations | |
|---|---|---|
Page 1
Page 1